Randomized, placebo-controlled study of oregovamab for consolidation of clinical remission in patients with advanced ovarian cancer

By Tait David  

The Women's Oncology Review, Vol. 5, Iss. 1, 2005-03 ,pp. : 27-28

Informa Healthcare

Access to resources Recommend Favorite

Randomized, placebo-controlled study of oregovomab for consolidation of clinical remission in patients with advanced ovarian cancer

By Thompson Patricia   Daud Adil   Lee H  

The Women's Oncology Review, Vol. 5, Iss. 3, 2005-09 ,pp. : 169-171

Informa Healthcare

Access to resources Recommend Favorite

Phase I Clinical Study of Three Times a Day Oral Administration of TAS-102 in Patients with Solid Tumors

By Overman Michael   Kopetz Scott   Varadhachary Gauri   Fukushima Masakazu   Kuwata Keizo   Mita Akira   Wolff Robert   Hoff Paulo   Xiong Henry   Abbruzzese James  

Cancer Investigation, Vol. 26, Iss. 8, 2008-10 ,pp. : 794-799

Informa Healthcare

Access to resources Recommend Favorite

A feasibility study on biweekly administration of docetaxel for patients with recurrent ovarian cancer*

By Oishi T.   Kigawa J.   Fujiwara K.   Fujiwara M.   Numa F.   Aotani E.   Katsumata N.   Kohno I.   Kato H.   Terakawa N.  

Gynecologic Oncology, Vol. 90, Iss. 2, 2003-08 ,pp. : 421-424

Elsevier

Access to resources Recommend Favorite

Ovarian cancer and high-risk women-implications for prevention, screening, and early detection

By Modugno F.   Ovarian Cancer and High-Risk Women Symposium Presenters  

Gynecologic Oncology, Vol. 91, Iss. 1, 2003-10 ,pp. : 15-31

Elsevier

Access to resources Recommend Favorite